Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients-Reference-Cited by-同舟云学术

Usefulness of therapeutic drug monitoring of rilpivirine and its relationship with virologic response and resistance in a cohort of naive and pretreated HIV‐infected patients

Published:2020-06 Issue:12 Volume:86 Page:2404-2413
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Néant Nadège¹^ORCID,Lê Minh Patrick²^ORCID,Bouazza Naïm³⁴⁵^ORCID,Gattacceca Florence⁶^ORCID,Yazdanpanah Yazdan⁷^ORCID,Dhiver Catherine⁸^ORCID,Bregigeon Sylvie⁹,Mokhtari Saadia⁸,Peytavin Gilles²^ORCID,Tamalet Catherine⁸^ORCID,Descamps Diane¹⁰^ORCID,Lacarelle Bruno¹^ORCID,Solas Caroline¹¹^ORCID

Affiliation:

1. Laboratoire de Pharmacocinétique et Toxicologie Aix Marseille Univ, APHM, INSERM, CNRS, CRCM SMARTc, Hôpital La Timone Marseille F‐13005 France

2. APHP, Hôpital Bichat‐Claude Bernard, Laboratoire de Pharmacologie‐Toxicologie, IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and INSERM Paris F‐75018 France

3. Université Paris Descartes EA7323, Sorbonne Paris Cité France

4. Unité de Recherche Clinique Paris Descartes Necker Cochin, AP‐HP France

5. CIC‐1419 Inserm, Cochin‐Necker Paris France

6. Aix Marseille Univ, INSERM, CNRS, CRCM SMARTc Marseille F‐13005 France

7. Univ Paris Diderot, APHP, IAME‐UMR 1137, Hôpital Bichat‐Claude Bernard, Service des Maladies Infectieuses et Tropicales Paris F‐75018 France

8. IHU Méditerranée Infection, Aix Marseille Univ., AP‐HM, URMITE UM 63 CNRS 7278 IRD 198 INSERM 1095 Marseille F‐13005 France

9. APHM, Hôpital Sainte‐Marguerite Service d'Immuno‐hématologie clinique Marseille F‐13009 France

10. APHP, Hôpital Bichat‐Claude Bernard, Laboratoire de Virologie, IAME, UMR 1137, Université Paris Diderot, Sorbonne Paris Cité and INSERM Paris F‐75018 France

11. Aix Marseille Univ, APHM, INSERM 1207, IRD 190, UVE, Hôpital La Timone, Laboratoire de Pharmacocinétique et Toxicologie Marseille F‐13005 France

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14344

Reference29 articles.

1. European Medicines Agency. (2011).Summary product of characteristics EVIPLERA.http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_‐_Product_Information/human/002312/WC500118802.pdf.

2. Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens

3. Rilpivirine versus efavirenz with tenofovir and emtricitabine in treatment-naive adults infected with HIV-1 (ECHO): a phase 3 randomised double-blind active-controlled trial

4. Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial

5. Rilpivirine vs. efavirenz-based single-tablet regimens in treatment-naive adults

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. In vitro models for neuropathic pain phenotypic screening in brain therapeutics;Pharmacological Research;2024-04

2. Physiologically‐based pharmacokinetic modelling of long‐acting injectable cabotegravir and rilpivirine in pregnancy;British Journal of Clinical Pharmacology;2024-02-10

3. Substrate-controlled divergent remote C–H and N–H polyfluoroarylation of 2-aminopyrimidines with polyfluoroarenes via Pd(ii)/Pd(0) catalysis;Chemical Communications;2024

4. Therapeutic drug monitoring of antiretroviral drugs for the management of human immunodeficiency infection;Therapeutic Drug Monitoring;2024

5. In Silico Pharmacokinetics Evaluation of Forgiveness for Doravirine and Rilpivirine;Therapeutic Drug Monitoring;2023-12-26